Cargando…
TGFβ2 is a Prognostic Biomarker for Gastric Cancer and is Associated With Methylation and Immunotherapy Responses
TGFβ signaling plays a key role in cancer progression and by shaping tumor architecture and inhibiting the anti-tumor activity of immune cells. It was reported that high expression of TGFβ can promote the invasion and metastasis of cancer cells in a variety of tumors. However, there are few studies...
Autores principales: | Han, Bangling, Fang, Tianyi, Wang, Yimin, Zhang, Yongle, Xue, Yingwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127534/ https://www.ncbi.nlm.nih.gov/pubmed/35620459 http://dx.doi.org/10.3389/fgene.2022.808041 |
Ejemplares similares
-
Association of the TGFβ gene family with microenvironmental features of gastric cancer and prediction of response to immunotherapy
por: Han, Bangling, et al.
Publicado: (2022) -
Prognostic importance of the preoperative New‐Naples prognostic score for patients with gastric cancer
por: Wang, Hao, et al.
Publicado: (2022) -
Prognostic Nutritional Index and Neutrophil-to-Lymphocyte Ratio Are Respectively Associated with Prognosis of Gastric Cancer with Liver Metatasis Undergoing and without Hepatectomy
por: Gao, Jialiang, et al.
Publicado: (2019) -
Comprehensive Characterization of RNA Processing Factors in Gastric Cancer Identifies a Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses
por: Lou, Shenghan, et al.
Publicado: (2021) -
Lymphocyte subset is more suitable than systemic inflammatory response biomarker and immunoglobulin in constructing prognostic nomogram model for advanced gastric cancer
por: Fang, Tianyi, et al.
Publicado: (2023)